Researchers developed a method to assess the ability of small molecules to bind to hundreds of human proteins using AI and ML ...

Tumors of epigenetic, not genetic, origin have been demonstrated, challenging the established idea that cancer is caused only by permanent changes to DNA ...

The University of Delaware broke ground on construction of the SABRE Center, a pilot scale biopharmaceutical manufacturing facility that will sit next to the National Institute for Innovation in ...

Researchers at Duke University developed a blood test that they showed could successfully predict knee osteoarthritis (OA) at least eight years before tell-tale signs of the disease appeared on x-rays ...

Two independent research teams have successfully regenerated mouse brain circuits in mice using neurons grown from rat stem cells.

Insilico Medicine is heading to the clinic with a treatment for methylthioadenosine phosphorylase (MTAP) deleted cancers.

CMS proposed Medicare’s CGT reimbursement policy matches Medicaid’s sickle cell disease policy, forming a unified government ...

New data-intensive platforms continue to leverage artificial intelligence tools for improved speed and failure rate ...

Regeneron Pharmaceuticals will use Mammoth Biosciences’ CRISPR-based ultracompact gene editing platform to develop in ...

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford ...

Researchers discovered in mice that conditions such as diabetes diagnosed in people with spinal cord injuries, can be linked to abnormal post-injury neuronal activity.

Antisense oligonucleotides (ASOs) have been shown to effectively rescue defects in preclinical Timothy syndrome models, a ...